MRE-269
Product Specifications
CAS Number
475085-57-5
Target
Prostaglandin Receptor
Related Pathways
Immunology/Inflammation, GPCR/G Protein
Purity
0.9957
Bioactivity
MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 (ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269 (ACT-333679) is an active metabolite of Selexipag (S253150) .
Smiles
N(CCCCOCC(O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3
Molecular Formula
C25H29N3O3
Molecular Weight
419.52
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS007173-20ug 20 µg
Thyroid Peroxidase (TPO) (NM_000547) Human Over-expression Lysate
Sign In for Pricing
View Details 
C7978-25C-PE 100 µL
CTGF (Connective Tissue Growth Factor, CCN2, Hcs24, Hypertrophic Chondrocyte-specific Gene Product 24, IGFBP8, Insulin-like Growth Factor-Binding Protein 8) (PE) discontinued
Sign In for Pricing
View Details 